Happy Trans Awareness Week!
Sharing a Trans/NB cancer study based in the UK aiming at improving cancer outcomes for Trans women and non-binary persons with a prostate:
Did you know that Trans and Gender-Diverse (TGD) individuals face distinct challenges in cancer care?
What the Data Tells Us:
Trans and Gender-Diverse people are:
- Significantly less likely to access routine cancer screening compared to non-trans individuals.
- Experiencing higher rates of specific cancer risks.
- Experiencing higher mortality rates and worse outcomes as a result of cancer.
- Continuing to face routine discrimination in healthcare settings and are offered less treatment options as compared to non-trans cancer patients.
The TransPRIDE study is investigating how gender-affirming care affects PSA (Prostate Specific Antigen), a blood test for prostate health, including cancer. This study will help doctors find and treat prostate cancer in trans women and non-binary people.
Learn more via Video link: https://vimeo.com/1225052217/524aa37809?share=copy&fl=sv&fe=ci
Who is eligible?
If you are a trans woman, transfemme, or non-binary person aged 40 or over in the UK with a prostate, this study is for you.
What does taking part involve?
If you choose to participate, you will need to make an appointment at one of TransPRIDE's eight study sites (including Ambrose King Sexual Health centre at RLH). You will be asked to read our patient information and sign a consent form. Some sites will ask you to do this in person and others can do this online.
For the study itself, you will complete a short questionnaire followed by a blood test. This test will look at your PSA, testosterone, oestrogen, LH (luteinising hormone) and FSH (follicle-stimulating hormone). You will get your results, and you will also receive a £25 voucher for your time.
Six months later, you will receive a telephone call from us to answer some follow-up questions about your health.
To find out more and to sign up, please visit the study website: https://transpridestudy.org.uk/
Help us improve cancer outcomes for Transfemmes this Trans Awareness Week!